Uni-Bio Science Group Ltd. is an investment holding company with interests in pharmaceutical research and development. The firm operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.
Follow-Up Questions
Uni-Bio Science Group Ltd 'in CEO'su kimdir?
Mr. Zhi Gang Zhao 2014 'den beri şirketle birlikte olan Uni-Bio Science Group Ltd 'in Chief Executive Officer 'ıdır.
UNBSF hissesinin fiyat performansı nasıl?
UNBSF 'in mevcut fiyatı $0 'dir, son işlem günde 0% decreased etti.
Uni-Bio Science Group Ltd için ana iş temaları veya sektörler nelerdir?
Uni-Bio Science Group Ltd Biotechnology endüstrisine ait ve sektör Health Care 'dir
Uni-Bio Science Group Ltd 'in piyasa değerlemesi nedir?
Uni-Bio Science Group Ltd 'in mevcut piyasa değerlemesi $0 'dir
